The significance of polymorphisms of gene coagulation factors VII and XIII in the pathogenesis of non-traumatic avascular necrosis of the femoral head

Introduction. Non-traumatic avascular necrosis of the femoral head (ANFH) is a poly-etiologic and socially significant disease in the age of 20 to 50 years and is associated with disability. Research on the identification of necrosis causes/predictors is a relevant issue.

Purpose. To study the contribution of polymorphisms in the genes of coagulation factors F7 and F13 in the aetiology of non-traumatic avascular necrosis of the femoral head.

Methods. Polymorphisms of the genes of coagulation factors F7 and F13 were studied; comparative analysis of the frequency of important allelic variants of F7genes (Arg353Gln) and F13 (Val134Leu) in patients with a verified diagnosis of aseptic necrosis (study group) and in healthy patients (control group) was performed. The study group included 41 patients (all males) with aseptic necrosis of the femoral head of unknown etiology.

Results. The frequency of gene alleles in the F7 Arg353Gln in the study group were: GG in 30 out of 41 patients (73.2 %), GA in 11 out of 41 patients (26.8 %), and none of 41 patients had a polymorphic variant AA. The frequency of alleles of this type of gene in the control group was as follows: GG in 7 out of 320 subjects (2.2 %), GA in 66 out of 320 patients (20.6 %), AA in 247 out of 320 (77.2 %). Significant differences were identified in the frequencies of homozygous genotypes, AA (χ2 = 100.215, p less 0.001) and GG (χ2 = 205.770, p less 0.001) in the study and control groups respectively. As for the heterozygous GA genotype, the differences were not significant (χ2 = 0.834, p = 0.362). The GG genotype of the gene Val134Leu F13 WAS 2.8 times more frequent in patients of the study group, differences were statistically significant (26.8 % against 9.7 %, χ2 = 10.388; p = 0.002). The presence of the TT genotype of the gene Val134Leu F13 was almost five times more frequent (χ2 = 18.956, p less 0.001) in healthy individuals (control group). Differences in the frequency of allele T in homo/and heterozygous combinations (TT and GT) in the study and control groups was also significant (72.7 % vs 90.1 %, respectively, χ2 = 4.946, p = 0.027).

Discussion. Polymorphisms of coagulation factors genes F7 and F13 have a significant effect on the genesis of non-traumatic avascular necrosis of the femoral head. Risk factor of ANFH development is homozygous GG genotype in the gene Arg353Gln F7. Low probability of the disease is due to a protective role of AA genotype of the gene Arg353Gln F7 and TT genotype of the gene Val134Leu F13.

1. Shannon B.D., Trousdale R.T. Femoral osteotomies for avascular necrosis of the femoral head. Clin. Orthop. Relat. Res., 2004, no. 418, pp. 34-40. DOI: 10.1097/00003086-200401000-00007.

2. DeSmet A.A., Dalinka M.K., Alazraki N.P., Daffner R.H., El-Khoury G.Y., Kneeland J.B. et al. Expert Panel on Musculoskeletal Imaging. Avascular necrosis of the hip. American College of Radiology (ACR), Reston (VA), 2005. URL: http://www.guidelines.gov/summary/summary.aspx?doc_id=8296&nbr=004628&string=avascular+AND+necrosis.

3. Mont M.A., Marulanda G.A., Jones L.C., Saleh K.J., Gordon N., Hungerford D.S., Steinberg M.E. Systematic analysis of classification systems for osteonecrosis of the femoral head. J. Bone Joint Surg. Am., 2006, vol. 88, no. 3, pp. 16-26. DOI: 10.2106/JBJS.F.00457.

4. Panin M.A., Zagorodnii N.V., Karchebnyi N.N., Sadkov I.A., Petrosian A.S., Zakirova A.R. Sovremennyi vzgliad na patogenez netravmaticheskogo osteonekroza [Modern view of the pathogenesis of non-traumatic osteonecrosis]. Vestnik Travmatologii i Ortopedii imeni N.N. Priorova [Priorov Bulletin of Traumatology and Orthopaedics], 2017, no. 2, pp. 69-75. (in Russian).

5. Jones L.C., Mont M.A., Le T.B., Petri M., Hungerford D.S., Wang P., Glueck C.J. Procoagulants and osteonecrosis. J. Rheumatol., 2003, vol. 30, no. 4, pp. 783-791.

6. Glueck C.J., Freiberg R.A., Oghene J., Fontaine R.N., Wang P. Association between the T-786C eNOS polymorphism and idiopathic osteonecrosis of the head of the femur. J. Bone Joint Surg. Am., 2007, vol. 89, no. 11, pp. 2460-2468. DOI: 10.2106/JBJS.F.01421.

7. Di Minno G., Grandone E., Margaglione M. Clinical relevance of polymorphic markers of arterial thrombosis. Thromb. Haemost., 1997, vol. 78, no. 1, pp. 462-466.

8. Grant P.J. Polymorphisms of coagulation/fibrinolysis genes: gene environment interactions and vascular risk. Prostaglandins Leukot. Essent. Fatty Acids., 1997, vol. 57, no. 4-5, pp. 473-477. DOI: 10.1016/s0952-3278(97)90431-2.

9. Kuznik B.I. Sistema gemostaza [Hemostasis System]. Fiziologiia Cheloveka, 2000, no. 1, pp. 313-325. (in Russian)

10. Golino P. The inhibitors of the tissue factor: factor VII pathway. Thromb. Res., 2002, vol. 106, no. 3, pp. V257-V265. DOI: 10.1016/s0049-3848(02)00079-8.

11. Kang W.Y., Wang H.L., Xiong L.F., Wang X.F., Chu H.Y., Qu B., Liu X.F., Yin J., Duan B.H., Wang Z.Y. Polymorphisms of the coagulation factor VII gene and its plasma levels in relation to acute cerebral infarction differences in allelic frequencies between Chinese Han and European populations. Chin. Med. J. (Engl), 2004, vol. 117, no. 1, pp. 71-74.

12. Komáromi I., Bagoly Z., Muszbek L. Factor XIII: novel structural and functional aspects. J. Thromb. Haemost., 2011, vol. 9, no. 1, pp. 9-20. DOI: 10.1111/j.1538-7836.2010.04070.x.

13. Muszbek L., Ariëns R.A., Ichinose A. ISTH SSC Subcommittee on Factor XIII. Factor XIII: recommended terms and abbreviation. J. Thromb. Haemost., 2007, vol. 5, no. 1, pp. 181-183. DOI: 10.1111/j.1538-7836.2006.02182.x.

14. Bronić A., Ferencak G., Zadro R., Stavljenić-Rukavina A., Bernat R. Impact of FXIII-A Val34Leu polymorphism on coronary artery disease in Croatian patients. Mol. Biol. Rep., 2009, vol. 36, no. 1, pp. 1-5. DOI: 10.1007/s11033-007-9144-9.

15. Narayanan A., Khanchandani P., Borkar R.M., Ambati C.R., Roy A., Han X., Bhoskar R.N., Ragampeta S., Gannon F., Mysorekar V., Karanam B., Sai Muthukumar V., Sivaramakrishnan V. Avascular Necrosis of Femoral Head: A Metabolomic, Biophysical, Biochemical, Electron Microscopic and Histopathological Characterization. Sci. Rep., 2017, vol. 7, no. 1, pp. 10721. DOI: 10.1038/s41598-017-10817-w.

16. Andreenko E.Iu., Samokhodskaia L.M., Balatskii A.V., Makarevich P.I., Boitsov S.A. Prognosticheskaia znachimost nositelstva allelnykh variantov genov, kontroliruiushchikh sistemu gemostaza, i ikh sochetaniia s traditsionnymi faktorami riska v rannem razvitii ishemicheskoi bolezni serdtsa [The prognostic significance of the carriage of allelic variants of genes that control the hemostasis system, and their combination with traditional risk factors in the early development of ischemic heart disease]. Kardiovaskuliarnaia Terapiia i Profilaktika, 2011, vol. 10, no. 8, pp. 32-39. (in Russian)

17. Ramzi M., Cohan N., Yavarian M., Jahromi M.R. Coagulation factor VII gene polymorphisms and cardiovascular diseases in Iranian population. J. Indian College of Cardiology, 2013, vol. 3, no. 1, pp. 6-8. DOI: 10.1016/j.jicc.2012.12.004.

18. Kreutz R.P., Bitar A., Owens J., Desta Z., Breall J.A., Von der Lohe E., Sinha A., Vatta M., Nystrom P., Jin Y., Flockhart D.A. Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease. J. Thromb. Thrombolysis, 2014, vol. 38, no. 3, pp. 380-387. DOI: 10.1007/s11239-014-1059-4.